Csenge Advisory Group Abbott Laboratories Transaction History

Csenge Advisory Group

$1.97 Billion
Q3 2024

A detailed history of Csenge Advisory Group transactions in Abbott Laboratories stock. As of the latest transaction made, Csenge Advisory Group holds 16,055 shares of ABT stock, worth $1.89 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

16,055

Previous 16,538 2.92%

Holding current value

$1.89 Million

Previous $1.72 Million 6.52%

% of portfolio

0.09%

Previous 0.1%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$100.07 - $118.13 $48,333 - $57,056	-483 Reduced 2.92%	16,055 $1.83 Million
Q2 2024 Jul 10, 2024	SELL	$100.73 - $112.44 $220,900 - $246,580	-2,193 Reduced 11.71%	16,538 $1.72 Million
Q1 2024 May 03, 2024	BUY	$109.52 - $120.96 $129,452 - $142,974	1,182 Added 6.74%	18,731 $2.13 Million
Q4 2023 Feb 13, 2024	BUY	$90.19 - $110.4 $172,984 - $211,747	1,918 Added 12.27%	17,549 $1.93 Million
Q3 2023 Nov 01, 2023	SELL	$95.53 - $114.62 $104,987 - $125,967	-1,099 Reduced 6.57%	15,631 $1.51 Million
Q2 2023 Jul 20, 2023	BUY	$100.78 - $112.29 $205,288 - $228,734	2,037 Added 13.86%	16,730 $1.82 Million
Q1 2023 May 01, 2023	BUY	$96.86 - $114.01 $92,695 - $109,107	957 Added 6.97%	14,693 $1.49 Million
Q4 2022 Feb 10, 2023	SELL	$95.06 - $111.52 $84,318 - $98,918	-887 Reduced 6.07%	13,736 $1.51 Million
Q3 2022 Oct 04, 2022	BUY	$96.76 - $112.03 $41,606 - $48,172	430 Added 3.03%	14,623 $1.42 Million
Q2 2022 Jul 27, 2022	BUY	$102.07 - $123.37 $54,505 - $65,879	534 Added 3.91%	14,193 $1.54 Million
Q1 2022 May 09, 2022	BUY	$114.02 - $139.04 $406,025 - $495,121	3,561 Added 35.26%	13,659 $1.62 Million
Q4 2021 Feb 10, 2022	SELL	$115.53 - $141.46 $282,817 - $346,294	-2,448 Reduced 19.51%	10,098 $1.18 Million
Q3 2021 Oct 20, 2021	BUY	$116.66 - $129.06 $285,583 - $315,938	2,448 Added 24.24%	12,546 $1.47 Million
Q2 2021 Jul 21, 2021	BUY	$105.79 - $124.53 $113,512 - $133,620	1,073 Added 11.89%	10,098 $1.18 Million
Q1 2021 Apr 28, 2021	SELL	$108.84 - $128.23 $38,855 - $45,778	-357 Reduced 3.81%	9,025 $1.09 Million
Q4 2020 Jan 26, 2021	SELL	$105.0 - $114.42 $69,405 - $75,631	-661 Reduced 6.58%	9,382 $1.03 Million
Q3 2020 Nov 09, 2020	BUY	$91.64 - $111.29 $98,329 - $119,414	1,073 Added 11.96%	10,043 $1.07 Million
Q2 2020 Jul 17, 2020	SELL	$76.57 - $98.0 $93,721 - $119,952	-1,224 Reduced 12.01%	8,970 $820,000
Q1 2020 Apr 21, 2020	BUY	$62.82 - $91.86 $185,004 - $270,527	2,945 Added 40.63%	10,194 $804,000
Q4 2019 Feb 05, 2020	BUY	$78.51 - $87.4 $39,726 - $44,224	506 Added 7.5%	7,249 $630,000
Q3 2019 Nov 14, 2019	SELL	$81.84 - $88.74 $140,191 - $152,011	-1,713 Reduced 20.26%	6,743 $564,000
Q2 2019 Jul 30, 2019	BUY	$72.88 - $85.0 $616,273 - $718,760	8,456 New	8,456 $711,000
Q4 2018 Feb 07, 2019	SELL	$65.56 - $74.27 $29,436 - $33,347	-449 Closed	0 $0
Q3 2018 Nov 19, 2018	BUY	$60.81 - $73.36 $27,303 - $32,938	449 New	449 $31,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Csenge Advisory Group, based on Form 13F filings with the SEC.

News

Stay updated on Csenge Advisory Group with notifications on news.

Account

Csenge Advisory Group Abbott Laboratories Transaction History